Product Information

HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Padagis US LLC, priced at $5.5719 per EA under NDC 00574029301. Its NADAC has been published 273 times since Jun 17, 2015.

FDA first approved this application on Apr 6, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the hydromorphone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROMORPHONE HCL ER 8 MG TAB

hydromorphone hydrochloride
$5.5719per EA
High Outlier
DEA Schedule CII

Strength

8 mg/1

Manufacturer

Padagis US LLC

NDC

00574029301

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204278

FDA Approved

4/6/2015

TE Code

AB

On Market Since

5/22/2015

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 273 times since Jun 17, 2015, and over the history we have for it it has declined 48.6%. The table below summarizes its recorded NADAC range and movement.

Current price$5.5719 per EA
All-time high$10.8378 (Jul 15, 2015)
All-time low$5.5719 (Nov 18, 2026)
52-week high$7.0165
52-week low$5.5719
Median price$7.5800
Average price$8.0232
Largest weekly change-24.6% (Jan 17, 2018)
Weeks tracked273
Tracking sinceJun 17, 2015

Price History

1W

-2.5%

1M

-2.7%

3M

-4.5%

6M

-13.5%

1Y

-12.9%

3Y

-20.4%

5Y

-20.4%

All

-48.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Padagis US LLC, is $5.5719 per EA (NDC 00574029301), effective Nov 18, 2026.

How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has declined 48.6%. It has been tracked across 273 weekly CMS publications since Jun 17, 2015.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?

Since Jun 17, 2015, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $5.5719 (Nov 18, 2026) to a high of $10.8378 (Jul 15, 2015), with a median of $7.5800 per EA.

Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5435 per EA — about 90% below HYDROMORPHONE HCL ER 8 MG TAB.

Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?

HYDROMORPHONE HCL ER 8 MG TAB (NDC 00574029301) is labeled by Padagis US LLC, and CMS classifies it as a generic product.